Concolino D, Muzzi G, Pisaturo L, Piccirillo A, Di Natale P, Strisciuglio Pietro
Department of Pediatrics, University "Magna Graecia" of Catanzaro, c/o Ospedale Civile "A.Pugliese", Viale Pio X, 88100 Catanzaro, Italy.
Eur J Med Genet. 2008 Sep-Oct;51(5):466-71. doi: 10.1016/j.ejmg.2008.05.002. Epub 2008 May 23.
To date the association between mucopolysaccharidosis (MPS) IIIA and precocious puberty has been found in only three polish patients. We observed two children affected by MPS IIIA with central precocious puberty (CPP) both treated with GnRH agonists. The occurrence of CPP in both patients with MPS IIIA suggests that it is necessary to look for an association between the two conditions. The follow-up of our two patients leads us to believe also that GnRH agonist treatment can have a beneficial effect on final height and probably on the improvement of behavioural problems.
迄今为止,仅在三名波兰患者中发现黏多糖贮积症IIIA型(MPS IIIA)与性早熟之间存在关联。我们观察到两名患有MPS IIIA型且伴有中枢性性早熟(CPP)的儿童均接受了促性腺激素释放激素(GnRH)激动剂治疗。两名MPS IIIA患者均出现CPP,这表明有必要探寻这两种病症之间的关联。对我们这两名患者的随访还使我们相信,GnRH激动剂治疗可能对最终身高有有益影响,并且可能有助于改善行为问题。